DRUG ABUSE TREATMENT--PROCESS, OUTCOMES, & SOCIAL POLICY

药物滥用治疗——过程、结果、

• 批准号: 6523122
• 负责人: MDouglas Douglas ANGLIN
• 金额: $ 11.37万
• 依托单位: UNIVERSITY OF CALIFORNIA LOS ANGELES
• 依托单位国家: 美国
• 财政年份: 2000
• 资助国家: 美国
• 起止时间: 2000-09-01 至 2005-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6523122
• 关键词: drug abuse therapy; health care policy; health science research; outcomes research; publications; substance abuse related behavior; training

DESCRIPTION: (Applicant's Abstract) This proposal represents a competing continuation application for salary support in the form of the K05 Senior Scientist Award in order to sustain my professional development. During the period of support provided by the current K02 (NIDA Grant DA00146), my work has contributed to the understanding of drug abuse phenomena, including its etiology, epidemiology, treatment, and related issues. Findings have significantly influenced social policy as well as clinical and research practices. Furthered by K02/RSDA funding support, my career development has proceeded along an increasingly sophisticated course to the point that I have achieved considerable stature as a senior scientist in the field of drug abuse research. As demonstrated by over 150 publications in scholarly journals and by my principal role on numerous large research projects over the past three decades, my reputation among my peers and the accomplishments of a long, productive research career validate the renewal of continued support under the K05 Career Award funding mechanism. During the next five years of K05 support I will continue to foster the expansion of the UCLA Drug Abuse Research Center (DARC) as its Co-Director and will pursue scientific evaluation of interventions for drug abuse and associated drug policies; I will also continue as the Director of the NIDA-funded Research Training Program at DARC and will continue publishing articles, books, and monographs to disseminate the experience gained during my career. Furthermore, I will be broadening my professional scope by participating as co-Principal Investigator on the UCLA Node of the NIDA Clinical Trials Network. Ongoing and future efforts reflect my emphasis on increasing and refining the knowledge base regarding drug-related issues, ultimately toward the goal of providing reliable findings that policymakers, clinicians, and researchers can use to gain a greater understanding of drug phenomena and to better address associated problems. As the co-Director of DARC, I am academically affiliated and supported by the UCLA Neuropsychiatric Institute (NPI), organized within the Department of Psychiatry at the UCLA School of Medicine.

描述：（申请人的摘要） 该提案代表了薪水的竞争延续申请 以K05高级科学家奖的形式提供支持，以维持我 专业发展。在当前提供的支持期间 K02（NIDA Grant DA00146），我的工作有助于对药物的理解 滥用现象，包括其病因，流行病学，治疗及相关现象 问题。调查结果极大地影响了社会政策以及 临床和研究实践。由K02/RSDA资金支持进一步 职业发展已经沿着越来越复杂的课程进行 作为高级科学家，我在 吸毒研究领域。正如150多个出版物所证明的 学术期刊以及我在众多大型研究项目中的主要角色 在过去的三十年中，我在同龄人中的声誉 漫长而富有成效的研究职业的成就验证了续约 K05职业奖奖金机制的持续支持。在下一个 五年的K05支持我将继续促进UCLA的扩展 药物滥用研究中心（DARC）作为其联合主任，并将追求科学 评估药物滥用和相关药物政策的干预措施；我会 还将继续担任NIDA资助的研究培训计划主任 Darc并将继续出版文章，书籍和专着 传播我职业生涯中获得的经验。此外，我会 通过参加联合主持调查员来扩大我的专业范围 在NIDA临床试验网络的UCLA节点上。持续和未来 努力反映了我强调增加和完善知识基础 关于与毒品有关的问题，最终朝着提供可靠的目标 决策者，临床医生和研究人员可以用来获得的发现 对药物现象的更多了解并更好地解决相关的 问题。作为DARC的联合主任，我在学术上是隶属的， 由UCLA神经精神研究所（NPI）的支持 加州大学洛杉矶分校医学院精神病学系。